What is William Blair’s Forecast for VERV Q1 Earnings?
Verve Therapeutics, Inc. (NASDAQ:VERV – Free Report) – William Blair issued their Q1 2026 earnings estimates for shares of Verve Therapeutics in a report issued on Thursday, February 27th. William Blair analyst M. Minter expects that the company will post earnings per share of ($0.77) for the quarter. William Blair has a “Outperform” rating on […]
Verve Therapeutics, Inc. (NASDAQ:VERV – Free Report) – William Blair issued their Q1 2026 earnings estimates for shares of Verve Therapeutics in a report issued on Thursday, February 27th. William Blair analyst M. Minter expects that the company will post earnings per share of ($0.77) for the quarter. William Blair has a “Outperform” rating on […]
